查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1526334

全球生命科学工具市场

Life Science Tools
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 849 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球生命科学工具市场预计将达到 2,646 亿美元

2023年全球生命科学工具市场估计为1,512亿美元，预计到2030年将达到2,646亿美元，2023年至2030年复合年增长率为8.3%。细胞生物学技术是本报告分析的细分领域之一，预计复合年增长率为 7.4%，到分析期结束时将达到 846 亿美元。分析期间，基因组学技术领域的复合年增长率预计为 8.6%。

美国市场预计535亿美元，中国预计复合年增长率12.5%

预计 2023 年美国生命科学工具市场规模将达 535 亿美元。中国作为全球第二大经济体，预计2030年市场规模将达311亿美元，2023-2030年分析期间复合年增长率为12.5%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 6.0% 和 7.7%。在欧洲，德国预计复合年增长率为 7.1%。

全球生命科学工具市场 - 主要趋势与驱动因素总结

生命科学工具涵盖用于研究生物系统的广泛技术和设备。这些工具包括先进的实验室设备、试剂、消耗品以及研究和临床环境中使用的软体。生命科学工具的关键组成部分是基因组学和蛋白​​质组学技术，分别包括 DNA序列测定和蛋白质分析。这些工具透过实现更准确、更有效率的调查方法，彻底改变了生物技术、医学和诊断等领域。高通量筛检、质谱和先进的成像技术对于生命科学研究至关重要，可以提供对细胞和分子过程的详细见解。将这些工具与生物资讯学相结合，使研究人员能够分析大型资料集，从而在了解疾病和开发标标靶治疗取得重大进展。随着用于癌症治疗的单株抗体受到越来越多的关注，全球市场预计将进一步扩大。近年来，许多单株抗体已被核准作为各种癌症的治疗剂。这些诊断和癌症治疗的核准预计将扩大生技药品的应用范围。

生命科学工具的主要创新之一是次世代定序仪(NGS) 技术的出现。 NGS 大大降低了基因组序列测定所需的成本和时间，促进了大规模基因组计划和个人化医疗的方法。另一个重要的进步是 CRISPR-Cas9。 CRISPR-Cas9 是一种基因编辑技术，为基因研究和治疗开闢了新途径。此外，单细胞分析工具使科学家能够以前所未有的细节研究细胞群的异质性，这对于理解癌症等复杂疾病至关重要。晶片实验室技术的发展使许多实验室流程实现了小型化和自动化，提高了效率并减少了对大样本量的需求。这些创新得到了强大的软体工具的支持，用于管理和解释产生的大量资料，从而能够从可行的见解中得出复杂的生物资讯。

生命科学工具市场的成长受到多种因素的推动，例如个人化医疗需求的成长、研发投资的增加以及技术进步。个人化医疗根据个人的遗传特征客製化治疗方法，在很大程度上依赖基因组和蛋白质组学工具，并正在推动这些领域的需求。来自政府机构、私人组织和创业投资的大量资金正在刺激研究计划和新工具的开发。人工智慧和机器学习演算法的发展等技术进步正在增强资料分析能力并加快发现过程。慢性病盛行率的不断上升以及对创新诊断和治疗解决方案的需求也是关键驱动因素。此外，生物技术和製药行业的扩张，加上新兴市场越来越多地采用生命科学工具，也促进了市场的成长。随着这些工具变得更容易获取并整合到各种研究和临床应用中，它们对健康和疾病管理的影响持续增长，推动了该领域的进一步发展。

受访企业范例（共295家）

  • Abbott Laboratories Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Carl Zeiss AG
  • Eppendorf SE
  • F. Hoffmann-La Roche AG
  • Hitachi High-Tech Corporation
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Instruments plc
  • PerkinElmer Inc.
  • QIAGEN NV
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 中东
  • 非洲

第四章 比赛

简介目录
Product Code: MCP22151

Global Life Science Tools Market to Reach US$264.6 Billion by 2030

The global market for Life Science Tools estimated at US$151.2 Billion in the year 2023, is expected to reach US$264.6 Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2023-2030. Cell Biology Technology, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$84.6 Billion by the end of the analysis period. Growth in the Genomics Technology segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$53.5 Billion While China is Forecast to Grow at 12.5% CAGR

The Life Science Tools market in the U.S. is estimated at US$53.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$31.1 Billion by the year 2030 trailing a CAGR of 12.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.0% and 7.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.1% CAGR.

Global Life Science Tools Market - Key Trends & Drivers Summarized

Life science tools encompass a broad spectrum of technologies and instruments used in the study of biological systems. These tools include advanced laboratory instruments, reagents, consumables, and software used in research and clinical settings. Key components of life science tools are genomics and proteomics technologies, which involve DNA sequencing and protein analysis respectively. These tools have revolutionized fields such as biotechnology, pharmaceuticals, and diagnostics by enabling more precise and efficient research methodologies. High-throughput screening, mass spectrometry, and advanced imaging techniques are integral to life science research, providing detailed insights into cellular and molecular processes. The integration of these tools with bioinformatics allows researchers to analyze large datasets, leading to significant advancements in understanding diseases and developing targeted therapies. The global market is expected to gain further from increasing attention on monoclonal antibodies for cancer therapy. In the recent years, a large number of monoclonal antibodies have secured the regulatory approval for treatment of different forms of cancer. These approvals for diagnosis and cancer therapy are slated to expand the application scope of biologics.

One of the major innovations in life science tools is the advent of next-generation sequencing (NGS) technologies. NGS has dramatically reduced the cost and time required for sequencing genomes, facilitating large-scale genomic projects and personalized medicine approaches. Another critical advancement is CRISPR-Cas9, a gene-editing technology that has opened new avenues for genetic research and therapy. Additionally, single-cell analysis tools are enabling scientists to study the heterogeneity of cell populations in unprecedented detail, which is crucial for understanding complex diseases such as cancer. The development of lab-on-a-chip technologies has miniaturized and automated many laboratory processes, increasing efficiency and reducing the need for large sample volumes. These innovations are supported by robust software tools that manage and interpret the vast amounts of data generated, making it possible to derive actionable insights from complex biological information.

The growth in the life science tools market is driven by several factors, including the increasing demand for personalized medicine, rising investments in research and development, and advancements in technology. Personalized medicine, which tailors treatments to individual genetic profiles, relies heavily on genomic and proteomic tools, driving demand in these areas. Significant funding from government bodies, private organizations, and venture capitalists is fueling research initiatives and the development of new tools. Technological advancements, such as the development of AI and machine learning algorithms, are enhancing data analysis capabilities and speeding up the discovery process. The growing prevalence of chronic diseases and the need for innovative diagnostic and therapeutic solutions are also key drivers. Furthermore, the expansion of biotechnology and pharmaceutical industries, coupled with the increasing adoption of life science tools in emerging markets, is contributing to market growth. As these tools become more accessible and integrated into various research and clinical applications, their impact on health and disease management continues to grow, propelling further advancements in the field.

Select Competitors (Total 295 Featured) -

  • Abbott Laboratories Inc.
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Carl Zeiss AG
  • Eppendorf SE
  • F. Hoffmann-La Roche AG
  • Hitachi High-Tech Corporation
  • Illumina, Inc.
  • Merck KGaA
  • Oxford Instruments plc
  • PerkinElmer Inc.
  • QIAGEN N.V.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • A Prelude to Life Sciences Tools
    • Global Economic Update
    • Competition
    • Players Pursue Product Launch & Innovation to Stay Relevant in Competitive Life Science Tools Market
    • Life Science Tools - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Market Analysis and Prospects
    • Global Life Science Tools Market Appears Primed for Healthy Growth Ahead
    • Cell Biology Holds Significant Revenue Stake
    • Hospitals Remain Primary End-User Segment
    • North America Maintains Front Rank in Global Life Science Tools Market
    • Asia-Pacific to Exhibit Impressive Growth
    • Salient Drivers Keeping Global Life Science Tools Market in Good Shape
    • Technology Trends in the Life Sciences Domain
    • Connected Devices, IoT Ecosystems to Transform the Life Science Landscape
    • Exponential Intelligence, Quantum Computing and Ambient Technologies to Make Headway
    • Cloud Platforms Ease Data Sharing
    • Life Sciences to Gain with Blockchain Edge
    • AI-enabled Automation to Deliver Tangible Benefits for All
    • Cybersecurity Needs Grow for Life Sciences
    • Intertwined Factors with Major Implications for Life Science Domain & Related Tools
    • Recent Market Activity
    • World Brands
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Trends in Life Science Sector Support Demand
    • Why Diagnostic Testing is Key to Mitigate Impact of Infectious Diseases?
    • 3D Cell Culture Transforms Life Sciences Industry
    • Global 3D Cell Culture Market in US$ Million: 2020 - 2027
    • Increasing Demand for 3D Cell Culture in Drug Discovery
    • Use of 3D Cell Culture for Regenerative Medicine
    • mRNA Technology Gains Spotlight in Life Sciences
    • Innovations in Instrumentation Expand Functionality and Drive Adoption of PCR
    • Synoptic Review of Quantitative PCR Technical Advancements in the Recent Years
    • Global qPCR and dPCR Instrumentation Market in US$ Million: 2020-2025
    • Genome Sequencing Experiences Host of Evolutionary Waves
    • Greater Integration of Genomic Technologies in the Development of Novel Diagnostics Tests
    • Next Generation Sequencing Drives the Market Growth
    • R&D Activity Remains Vibrant in NGS
    • The Need for Large-scale NGS Data Analysis Pushes for Cloud-enabled Bioinformatics Services
    • Single-Cell Spatial Biology Technologies Poised to Emerge as an Integral Aspect of Future Labs
    • Rising Application of Whole Genome Sequencing Drives Demand for Faster Secondary Analysis Tools
    • Rapid Growth in Biopharma Industry and Rising Investments in R&D to Boost Market Prospects
    • Global BioPharmaceuticals Market in US$ Billion: 2020 and 2026
    • Liquid Chromatography Drives Growth in New Application Markets
    • Innovative HPLC Products Inject New Growth
    • Digital Transformation of Life Sciences Sector Improves Efficiency and Productivity
    • Key Initiators of Digital Transformation in Life Sciences
    • Artificial Intelligence offers Multiple Opportunities
    • Wearable Devices Gains Popularity
    • The Cloud Technology Witnesses Rapid Growth
    • VR and E-pharmacy
    • Smart Quality
    • Growing R&D Spending in Pharma and Biotechnology Sectors Presents Opportunities
    • Pharmaceutical R&D Spending Worldwide (USD Billion) for 2015-2025
    • Technological Developments and Expanding End-Use Applications to Bolster Growth in Mass Spectrometry
    • Global Chromatography Market (2022): Percentage Share Breakdown of Value Sales by Chromatography Techniques
    • Miniature Mass Spectroscopy Instruments Get Popular
    • Increase in Healthcare Spending to Propel Demand for Life Science Tools
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017-2023
    • The Rise of Data Analytics in Life Sciences
    • Data Science in Drug R&D
    • Data Sharing Emerges as a Significant Trend to Gain Competitive Advantage
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Life Science Tools Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Life Science Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Life Science Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Cell Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Cell Biology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Genomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Genomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Proteomics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Proteomics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Healthcare by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Healthcare by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Biopharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Biopharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Government & Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Government & Academics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Government & Academics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Life Science Tools by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Life Science Tools by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • TABLE 62: France Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Life Science Tools by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Life Science Tools by Geographic Region - Percentage Breakdown of Value Revenues for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Life Science Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 143: Middle East Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Middle East Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Middle East 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 146: Middle East Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Middle East Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Middle East 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • TABLE 149: Africa Recent Past, Current & Future Analysis for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Africa Historic Review for Life Science Tools by Technology - Cell Biology, Genomics, Proteomics and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Africa 16-Year Perspective for Life Science Tools by Technology - Percentage Breakdown of Value Revenues for Cell Biology, Genomics, Proteomics and Other Technologies for the Years 2014, 2024 & 2030
    • TABLE 152: Africa Recent Past, Current & Future Analysis for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Africa Historic Review for Life Science Tools by End-Use - Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Africa 16-Year Perspective for Life Science Tools by End-Use - Percentage Breakdown of Value Revenues for Healthcare, Biopharmaceutical Companies, Government & Academics and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION